Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

10x Genomics, Inc. (TXG) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

10x Genomics, Inc. (TXG), most recent 12 months reported: revenue $616.91M, net loss $75.13M, free cash flow $121.44M. Latest balance sheet on file: liquid cash $552.03M. From SEC filings. Others in Laboratory Analytical Instruments: Mettler-Toledo International Inc. · BRUKER CORPORATION · REVVITY, INC · BIO-RAD LABORATORIES, INC. · CYTEK BIOSCIENCES, INC. · Pacific Biosciences of California, Inc. · Quanterix Corporation · HARVARD BIOSCIENCE, INC.

Stock screener

Watchlist